DENTSPLY SIRONA (NASDAQ:XRAY – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.
Analyst Ratings
This is a summary of current ratings for DENTSPLY SIRONA and Nexalin Technology, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| DENTSPLY SIRONA | 3 | 9 | 3 | 0 | 2.00 |
| Nexalin Technology | 1 | 0 | 0 | 0 | 1.00 |
DENTSPLY SIRONA currently has a consensus price target of $13.31, indicating a potential upside of 39.49%. Given DENTSPLY SIRONA’s stronger consensus rating and higher possible upside, equities analysts plainly believe DENTSPLY SIRONA is more favorable than Nexalin Technology.
Profitability
| Net Margins | Return on Equity | Return on Assets | |
| DENTSPLY SIRONA | -14.99% | 20.84% | 5.32% |
| Nexalin Technology | -4,141.94% | -278.24% | -218.42% |
Volatility and Risk
DENTSPLY SIRONA has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Comparatively, Nexalin Technology has a beta of 3.95, meaning that its share price is 295% more volatile than the S&P 500.
Institutional & Insider Ownership
95.7% of DENTSPLY SIRONA shares are owned by institutional investors. Comparatively, 0.7% of Nexalin Technology shares are owned by institutional investors. 0.5% of DENTSPLY SIRONA shares are owned by company insiders. Comparatively, 16.9% of Nexalin Technology shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Earnings and Valuation
This table compares DENTSPLY SIRONA and Nexalin Technology”s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| DENTSPLY SIRONA | $3.68 billion | 0.52 | -$598.00 million | ($2.75) | -3.47 |
| Nexalin Technology | $300,000.00 | 11.92 | -$8.22 million | ($14.41) | -0.34 |
Nexalin Technology has lower revenue, but higher earnings than DENTSPLY SIRONA. DENTSPLY SIRONA is trading at a lower price-to-earnings ratio than Nexalin Technology, indicating that it is currently the more affordable of the two stocks.
Summary
DENTSPLY SIRONA beats Nexalin Technology on 9 of the 14 factors compared between the two stocks.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc. manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform. It also provides endodontic products consisting of motorized endodontic handpieces, files, sealers, irrigation needles, and other tools that support root canal procedures; restorative products, including dental ceramics, crowns, and veneers; and preventative products, such as curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, and impression materials. In addition, the company offers SureSmile and Byte aligner solutions; VPro/HyperByte, a high-frequency vibration technology device; SureSmile Simulator, which creates a 3D visualization of a patient's outcome; and Byte Plus for treatment planning. Further, it provides dental implants, digital dentures, crown and bridge porcelain products, bone regenerative and restorative solutions, treatment planning software, and educational programs; dental prosthetics; urology catheters; and other health-related consumables. The company serves professional dental and consumable medical device markets through third-party distributors. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1877 and is headquartered in Charlotte, North Carolina
About Nexalin Technology
Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3, that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, alzheimer's disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive and undetectable to the human body that can provide relief to its afflicted with mental health issues. The company is based in Houston, Texas.
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.
